期刊文献+

用液相色谱-质谱-质谱法测定人血清中非洛地平浓度 被引量:3

Quantitative determination of felodipine in human serum by LC-MS-MS method
下载PDF
导出
摘要 目的:建立液相色谱-质谱-质谱(LC-MS-MS)法测定人血清中非洛地平的浓度。方法:血清样品经液-液萃取预处理。色谱柱为Xterra柱(50 mm×2.1 mm,3.5μm),流动相为乙腈-0.02%氨水,采用梯度洗脱,流速为0.3 mL/min。非洛地平和尼莫地平(内标)的多反应监测(MRM)扫描离子对分别为m/z382.1→145和m/z417.2→92,两者的保留时间分别为1.24 min和1.06 min。结果:非洛地平在0.04~20 ng/mL范围内线性关系良好(r=0.999 7),低、中、高浓度(0.08、8.0、16.0 ng/mL)的日内RSD分别为6.60%、7.22%和5.01%(n=6),日间RSD分别为9.42%、8.46%和5.12%(n=14),准确度为98.21%~106.20%(n=6)。结论:本法操作简便,检测准确、灵敏、专一,重复性好,适用于非洛地平血药浓度监测和药动学及生物利用度研究。 Objective: To establish a LC-MS-MS method for determining the concentration of felodipine in human serum. Methods:The serum samples were pretreated by liquid-liquid extraction. The chromatographic column was a Xterra column (50 mm×2.1 mm, 3.5 μm). The mobile phase consisting of acetonitrile-0.02% ammonia water was eluted at a flow rate of 0.3 mL/min with gradient program. Felodipine and its internal standard nimodipine was monitored in multiple reaction monitoring(MRM) mode. The fragmentation transitions from precursor to production were m/z 382. 1/145 for felodipine and m/z 417.2/92 for nimodipine. The retention time of felodipine and nimodipine was 1.24 and 1.06 min, respectively. Results: For felodipine, the linear range was 0.04-20 ng/mL (r= 0. 999 7). At low, middle and high concentrations(0.08,8.0,16.0 ng/mL), the intra-day RSDs were 6. 60%,7. 22% and 5.01% (n=6) ,the inter-day RSDs were 9. 42%,8. 46% and 5. 12%(n= 14) ,and the accuracy rates were 98.2%- 106.20%( n = 6 ). Conclusion: This method is simple, accurate, sensitive, specific and reproducible for the determination of felodipine in human serum. It is suitable for therapeutic drug monitoring,pharmacokinetic and bioavailability study of felodipine.
出处 《药学服务与研究》 CAS CSCD 2007年第4期253-255,共3页 Pharmaceutical Care and Research
关键词 非洛地平 色谱法 高压液相 光谱分析 质量 血药浓度 felodipine chromatography, high pressure liquid spectrum analysis, mass plasma concentration
  • 相关文献

参考文献7

二级参考文献16

  • 1丁养军,尤进茂.序贯单纯形法确定高效液相色谱流动相各组分的最佳配比[J].色谱,1995,13(6):475-478. 被引量:14
  • 2Dru J D,J Chromatogr B,1995年,666卷,259页 被引量:1
  • 3徐积恩,中国新药杂志,1992年,1卷,26页 被引量:1
  • 4Nishioka R,J Chromatogr B,1991年,565卷,237页 被引量:1
  • 5刘皋林,国外医药.合成药、生化药、制剂分册,1991年,12卷,96页 被引量:1
  • 6徐晋,中国药理学通报,1990年,6卷,52页 被引量:1
  • 7刘昌孝,孙瑞元.药代动力学研究[A].见:刘昌孝,孙瑞元,主编.药物评价实验设计与统计学基础[M].北京:军事医学科学出版社,1999:127-8 被引量:1
  • 8Nishioka R, Umeda I, Qi NB. Determination of felodipine and its metabolites in plasma using capillary gas chromatography with electron-capture detection and their identification by gas chromatography-mass spectrometry [ J]. J Chromatogr B: Biomed Appl,1991 ;565:237 - 41 被引量:1
  • 9Dru JD, Hsieh JY, Matuszewski BK, Dobrinska MR. Determination of felodipine, its enantioners, and a pyridine in human plasma by capillary gas chromatography with mass-spectroetric detection[ J]. J Chromatogr B: Biomed Appl, 1995; 666: 259 - 67 被引量:1
  • 10U. S. Department of Health and Human Services, Food and Drug Administration. Guidance for industry: Bioanalyticai method validation[ S ]. 2001.4 - 10. 被引量:1

共引文献27

同被引文献23

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部